Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £73.24m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Portfolio Update and Unaudited Net Asset Value

9 Dec 2015 16:15

RNS Number : 5662I
Maven Income and Growth VCT 5 PLC
09 December 2015
Β 

Maven Income and Growth VCT 5 PLC

Β 

Β 

Portfolio Update and Unaudited Net Asset Value

Β 

Β 

The Directors of Maven Income and Growth VCT 5 PLC ("the Company") are pleased to confirm that, on 9 December 2015, the Company completed the disposal of its investment in Westway Services Holdings (2014) Limited ("Westway").

Β 

As a result of the Westway disposal, the Company's unaudited net asset value per share will increase by approximately 1.0p, an increase of approximately 2.5% from the unaudited net asset value per share of 39.33p as at 31 August 2015.

Β 

The Company's unaudited net asset value as at 30 November 2015 will be announced late January 2016.

Β 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

9 December 2015

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
PFUFSWFMUFISESE
Date   Source Headline
6th Jul 20264:51 pmRNSTransaction in Own Shares
3rd Jul 20264:16 pmRNSTransaction in Own Shares
1st Jul 20262:04 pmRNSUnaudited Net Asset Value and Interim Dividend
20th May 202610:20 amRNSAdmission of Further Securities to Trading
15th May 202610:10 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:39 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20264:10 pmRNSTransaction in Own Shares
28th Apr 20263:55 pmRNSResult of AGM
28th Apr 20261:35 pmRNSResult of AGM
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:30 amRNSAdmission of Further Securities to Trading
14th Apr 202611:11 amRNSIssue of Equity
8th Apr 20269:35 amRNSAdmission of Further Securities to Trading
27th Mar 20265:07 pmRNSOffer for Subscription - Fully Subscribed
25th Mar 202610:59 amRNSAdmission of Further Securities to Trading
25th Mar 20267:00 amRNSAnnual Financial Report
24th Mar 202612:13 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSUnaudited Net Asset Value
3rd Mar 20264:31 pmRNSTransaction in Own Shares - correction
27th Feb 20265:04 pmRNSTransaction in Own Shares
26th Feb 20264:53 pmRNSTransaction in Own Shares
26th Feb 20269:15 amRNSDividend Declaration
18th Feb 20265:01 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:11 amRNSDirector/PDMR Shareholding
17th Feb 202610:58 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:13 amRNSAdmission of Further Securities to Trading
16th Jan 20269:47 amRNSIssue of Equity
14th Jan 20262:44 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202511:15 amRNSDirector/PDMR Shareholding
16th Dec 202510:30 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:45 pmRNSResult of General Meeting
7th Oct 20254:15 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:11 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:17 pmRNSStatement re Dividend Investment Scheme
17th Jul 20253:21 pmRNSHalf-year Report
16th Jul 20255:33 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:50 pmRNSStatement re Unaudited NAV and Interim Dividend
14th May 20254:46 pmRNSTransaction in Own Shares
9th May 20259:59 amRNSIssue of Equity
6th May 202511:55 amRNSIssue of Equity
2nd May 20251:27 pmRNSUnaudited NAV - Dividend Investment Scheme
29th Apr 20253:20 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
15th Apr 20259:32 amRNSDirector/PDMR Shareholding
4th Apr 20256:22 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.